Stable Nonsegmental Vitiligo

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Stable Nonsegmental Vitiligo trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07437560

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard…

China60 participantsStarted 2026-02-02

Treatment: Melanotan II (MT-II), Placebo

All recent trials (5 shown)

Active — Not RecruitingPhase 3

NCT06163326

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

This study is to evaluate how safe and effective ritlecitinib is in participants with non-segmental vitiligo (NSV). Ritlecitinib is studied in patients with no…

United States394 participantsStarted 2024-01-19

Treatment: Ritlecitinib, Ritlecitinib 100 mg

Active — Not RecruitingPhase 3

NCT06072183

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

The purpose of this study is to learn about the safety and effects of the study medicine ritlecitinib for the possible treatment of nonsegmental vitiligo. Vitil…

United States1,571 participantsStarted 2023-11-08

Treatment: Ritlecitinib, Ritlecitinib

Stable Nonsegmental Vitiligo

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

All recent trials (5 shown)

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

All recent trials (5 shown)

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) T…

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells